Quality of care associated with common chronic diseases in a 9-state medicaid population utilizing claims data: An evaluation of medication and health care use and costs

Population Health Management

Volumn 14, Issue 1, 2011, Pages 43-54

  Priest, Julie L ^a   Cantrell, C Ron ^a   Fincham, Jack ^b   Cook, Christopher L ^a   Burch, Steven P ^a  

^a GLAXOSMITHKLINE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLITAZONE DERIVATIVE; INSULIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEGLITINIDE; MONOAMINE OXIDASE INHIBITOR; NITRATE; PHENYLALANINE DERIVATIVE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SULFONYLUREA; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VASODILATOR AGENT; XANTHINE;

ADULT; ARTICLE; ASTHMA; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY DISEASE; DEPRESSION; DIABETES MELLITUS; FEMALE; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAID; PATIENT COMPLIANCE; THROMBOEMBOLISM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICAID; MIDDLE AGED; QUALITY OF HEALTH CARE; UNITED STATES; YOUNG ADULT;

EID: 79951734643     PISSN: 19427891     EISSN: 19427905     Source Type: Journal    
DOI: 10.1089/pop.2010.0019     Document Type: Article

References (32)

1. McGlynn EA, Asch SM, A (Pubitemid 36741592)
2. Giacovelli JK, Egorova N, Nowygrod R, et al. Insurance status predicts access to care and outcomes of vascular disease. J Vasc Surg 2008;48:905-911.
3. Blanchard J, Ogle K, Thomas O, Lung D, Asplin B, Lurie N. Access to appointments based on insurance status in Washington, D.C. J Health Care Poor Underserved 2008;19:687-696.
4. Zhang JX, Huang ES, Drum ML, et al. Insurance status and quality of diabetes care in community health centers. Am J Public Health 2008;99:742-747.
5. Landon BE, Schneider EC, Normand SL, Scholle SH, Pawlson LG, Epstein AM. Quality of care in Medicaid managed care and commercial health plans. JAMA 2007;298: 1674-1681. (Pubitemid 47606656)
6. Melfi CA, Croghan TW, Hanna MP, Robinson RL. Racial variation in antidepressant treatment in a Medicaid population. J Clin Psychiatry 2000;61:16-21. (Pubitemid 30104378)
7. Shenolikar R, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc 2006;98: 1071-1077. (Pubitemid 44167770)
8. Bagchi AD, Esposito D, Kim M, Verdier J, Bencio D. Utilization of, and adherence to, drug therapy among Medicaid beneficiaries with congestive heart failure. Clin Ther 2007; 29:1771-1783. (Pubitemid 47494549)
9. Donnelly LA, Morris AD, Evans JM. Adherence to insulin and its association with glycaemic control in patients with type 2 diabetes. QJM 2007;100:345-350. (Pubitemid 47073810)
10. Kennedy S, McIntyre R, Fallu A, Lam R. Pharmacotherapy to sustain the fully remitted state. J Psychiatry Neurosci 2002;27:269-280. (Pubitemid 34988907)
11. White TJ, Vanderplas A, Ory C, Dezii CM, Chang E. Economic impact of patient adherence with antidepressant therapy within a managed care organization. Dis Manag Health Outcomes 2003;11:817-822. (Pubitemid 38156313)
12. Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL. Prevalence and economic consequences of medication adherence in diabetes: A systematic literature review. Manag Care Interface 2006;19:31-41. (Pubitemid 44148014)
13. Denhaerynck K, Manhaeve D, Dobbels F, Garzoni D, Nolte C, De Geest S. Prevalence and consequences of nonadherence to hemodialysis regimens. Am J Crit Care 2007;16:222-225.
14. Leucht S, Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry 2006;67:3-8. (Pubitemid 43837695)
15. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care 2005;43:521-530. (Pubitemid 40847288)
16. Thomson Reuters. Marketscan research databases. Available at: http://thomsonreuters.com/products-services/healthcare/healthcare-products/ pharmaceuticals/epidemiology-res/mktscan-res-db. Accessed May 20, 2010.
17. National Heart, Lung, and Blood Institute. Expert Panel Report 3: Guidelines for the diagnosis and management of asthma. Available at: http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf. Accessed June 8, 2008.
18. Donahue JG, Weiss ST, Livingston JM, Goetsch MA, Greineder DK, Platt R. Inhaled steroids and the risk of hospitalization for asthma. JAMA 1997;277:887-891. (Pubitemid 27123948)
19. American Thoracic Society/European Respiratory Society Task Force. Standards for the diagnosis and management of patients with COPD [Internet]. Version 1.2. New York: American Thoracic Society [Updated 2005 September 8]. Available at: http://www.thoracic.org/go/copd.
20. Kaiser Permanente Care Management Institute. Depression clinical practice guidelines. Oakland (CA): Kaiser Permanente Care Management Institute; 2006:196.
21. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2004;27:S15-S35.
22. Smith SC, Allen J, Blair S, et al. AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006;113:2363-2372. (Pubitemid 43947981)
23. Rodbard WH, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endoc Pract 2007;13:1-68.
24. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Summary article. J Am Coll Cardiol 2005;46:1116-1143.
25. Eert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
26. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252. (Pubitemid 37553153)
27. Sabaté E. Adherence to long-term therapies: evidence for action. Available at: http://www.who.int/chp/knowledge/publications/adherence-report/en/ . Accessed June 25, 2007.
28. Masand PS. Tolerability and adherences issues in antidepressant therapy. Clin Therapeut 2003;25:2289-2304. (Pubitemid 37076320)
29. Lin EH, Von Korff M, Katon W, et al. The role of the primary care physician in patients adherence to antidepressant therapy. Med Care 1995;33:67-74.
30. Maddox JC, Levi M, Thompson C. The compliance with antidepressants in general practice. J Psychopharmacol 1994;8:48-53. (Pubitemid 24092317)
31. Rand C, Bilderback A, Schiller K, et al. Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the mild asthma montelukast versus inhaled corticosteroid trial. J Allergy Clin Immunol 2007;119:916-923. (Pubitemid 46546427)
32. Gill JM, Landon BE, Antonelli RC, Rich EC. Generating the knowledge needed to make the patient-centered medical home a reality: A collaborative project of the primary care specialties. Ann Fam Med 2010;8:88-89.